A Comparative Study of Entecavir vs. Adefovir Plus Lamivudine vs Combination Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Subjects: The DEFINE Study.

Trial Profile

A Comparative Study of Entecavir vs. Adefovir Plus Lamivudine vs Combination Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Subjects: The DEFINE Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Oct 2013

At a glance

  • Drugs Adefovir dipivoxil (Primary) ; Entecavir (Primary) ; Lamivudine; Tenofovir disoproxil fumarate
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Acronyms DEFINE
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 10 Nov 2012 Status changed from active, no longer recruiting to completed.
    • 03 Jul 2012 Actual patient number is 629 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top